{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T05:23:54Z","timestamp":1648617834394},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2003,2,12]]},"DOI":"10.1001\/jama.289.6.690","type":"journal-article","created":{"date-parts":[[2003,3,18]],"date-time":"2003-03-18T15:05:58Z","timestamp":1047999958000},"page":"690","source":"Crossref","is-referenced-by-count":0,"title":["Agency Offers Guidance on Office-Based Drug Treatment for Opioid Addiction"],"prefix":"10.1001","volume":"289","author":[{"given":"Mike","family":"Mitka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/195937\/jmn0212_690_690_1614100614.28775.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T17:31:10Z","timestamp":1614101470000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/195937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,12]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,2,12]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.289.6.690","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2,12]]}}}